Ad is loading...
GEDSF
Price
$24.85
Change
-$0.00 (-0.00%)
Updated
Apr 3 closing price
UPC
Price
$0.14
Change
-$0.02 (-12.50%)
Updated
Nov 15 closing price
Ad is loading...

GEDSF vs UPC

Header iconGEDSF vs UPC Comparison
Open Charts GEDSF vs UPCBanner chart's image
Gedeon Richter
Price$24.85
Change-$0.00 (-0.00%)
Volume$9.5K
CapitalizationN/A
Universe Pharmaceuticals
Price$0.14
Change-$0.02 (-12.50%)
Volume$2.16M
CapitalizationN/A
GEDSF vs UPC Comparison Chart
Loading...
UPC
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
GEDSF vs. UPC commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GEDSF is a Hold and UPC is a Sell.

COMPARISON
Comparison
Nov 18, 2024
Stock price -- (GEDSF: $23.68 vs. UPC: $0.14)
Brand notoriety: GEDSF and UPC are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: GEDSF: 100% vs. UPC: 58%
Market capitalization -- GEDSF: $4.66B vs. UPC: $7.98M
GEDSF [@Pharmaceuticals: Other] is valued at $4.66B. UPC’s [@Pharmaceuticals: Other] market capitalization is $7.98M. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.45B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GEDSF’s FA Score shows that 2 FA rating(s) are green whileUPC’s FA Score has 0 green FA rating(s).

  • GEDSF’s FA Score: 2 green, 3 red.
  • UPC’s FA Score: 0 green, 5 red.
According to our system of comparison, both GEDSF and UPC are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

UPC’s TA Score shows that 4 TA indicator(s) are bullish.

  • UPC’s TA Score: 4 bullish, 3 bearish.

Price Growth

GEDSF (@Pharmaceuticals: Other) experienced а 0.00% price change this week, while UPC (@Pharmaceuticals: Other) price change was -44.17% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -5.07%. For the same industry, the average monthly price growth was -7.87%, and the average quarterly price growth was -11.90%.

Reported Earning Dates

UPC is expected to report earnings on Feb 10, 2023.

Industries' Descriptions

@Pharmaceuticals: Other (-5.07% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
GEDSF($4.66B) has a higher market cap than UPC($7.99M). GEDSF has higher P/E ratio than UPC: GEDSF (12.68) vs UPC (3.00). GEDSF YTD gains are higher at: 4.853 vs. UPC (-93.000). GEDSF has higher annual earnings (EBITDA): 201B vs. UPC (-7.29M). GEDSF has more cash in the bank: 106B vs. UPC (5.71M). UPC has less debt than GEDSF: UPC (3.94M) vs GEDSF (36.9B). GEDSF has higher revenues than UPC: GEDSF (773B) vs UPC (40.1M).
GEDSFUPCGEDSF / UPC
Capitalization4.66B7.99M58,410%
EBITDA201B-7.29M-2,758,035%
Gain YTD4.853-93.000-5%
P/E Ratio12.683.00423%
Revenue773B40.1M1,927,681%
Total Cash106B5.71M1,856,067%
Total Debt36.9B3.94M937,500%
FUNDAMENTALS RATINGS
GEDSF: Fundamental Ratings
GEDSF
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
2
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
2
PRICE GROWTH RATING
1..100
69
P/E GROWTH RATING
1..100
88
SEASONALITY SCORE
1..100
30

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
UPC
RSI
ODDS (%)
Bullish Trend 3 days ago
76%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
89%
Momentum
ODDS (%)
Bearish Trend 3 days ago
90%
MACD
ODDS (%)
N/A
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
90%
Advances
ODDS (%)
Bullish Trend 7 days ago
84%
Declines
ODDS (%)
Bearish Trend 3 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
87%
Aroon
ODDS (%)
Bearish Trend 3 days ago
90%
View a ticker or compare two or three
Ad is loading...
UPC
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
IFS28.300.24
+0.86%
Intercorp Financial Services
ABUS3.640.01
+0.28%
Arbutus Biopharma Corp
OPBK16.51-0.19
-1.14%
OP Bancorp
DT52.35-1.52
-2.82%
Dynatrace
APTO0.36-0.02
-5.28%
Aptose Biosciences

GEDSF and

Correlation & Price change

A.I.dvisor indicates that over the last year, GEDSF has been loosely correlated with APNHF. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if GEDSF jumps, then APNHF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GEDSF
1D Price
Change %
GEDSF100%
N/A
APNHF - GEDSF
51%
Loosely correlated
N/A
PNXP - GEDSF
47%
Loosely correlated
N/A
MSTH - GEDSF
22%
Poorly correlated
N/A
UPC - GEDSF
4%
Poorly correlated
-13.20%
AYRWF - GEDSF
3%
Poorly correlated
-1.28%
More